How to Use

IMPACT® may be administered via gastric or small bowel feeding tubes. A thorough patient assessment should be made before determining the appropriate enteral access route and type of feeding tube. For patients undergoing abdominal surgery, consider surgical feeding tube placement to facilitate early enteral feeding.

• Initiate full-strength IMPACT® slowly at desired rate per facility protocol. Monitor patient closely and advance feeding as tolerated until at least 50% of patient's caloric goals are met. Avoid overfeeding to help decrease the risk of metabolic complications, such as hyperglycemia or increased carbon dioxide production.
• IMPACT® should be used for at least 5 days. Patients may not receive maximum benefit from IMPACT® if used fewer than five days.
• IMPACT® should be continued until the risk of infectious complications is significantly reduced. Objective criteria for discontinuation of IMPACT® include a decrease in inflammatory proteins (C-reactive protein or fibronectin) or an increase in prealbumin. The patient then should be transitioned to a high-nitrogen formula.